rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
10
|
pubmed:dateCreated |
1999-11-19
|
pubmed:abstractText |
The prognosis of Ewing's tumor patients has been improved gradually through cooperative therapy studies, so that meanwhile 55 to 65% of the patients survive relapse-free in the long term. Patients with multifocal primary, early or multiply-relapsed Ewing's tumors have a dismal prognosis. Megatherapy with subsequent stem cell transplantation seems to improve outcome in this patient cohort. Feasibility of this intense megatherapy regimen is crucially dependent on collaboration and multidisciplinary coordination of radiologists, radiotherapists, surgeons and oncologists.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0179-7158
|
pubmed:author |
pubmed-author:BurdachSS,
pubmed-author:DirksenUU,
pubmed-author:Dockhorn-DworniczakBB,
pubmed-author:EngelBB,
pubmed-author:GöbelUU,
pubmed-author:HeyllAA,
pubmed-author:JürgensHH,
pubmed-author:KörholzDD,
pubmed-author:KahnTT,
pubmed-author:LawsH JHJ,
pubmed-author:MerckHH,
pubmed-author:PapeHH,
pubmed-author:SchmittCC,
pubmed-author:van KaichGG
|
pubmed:issnType |
Print
|
pubmed:volume |
175
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
488-94
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10554643-Adolescent,
pubmed-meshheading:10554643-Adult,
pubmed-meshheading:10554643-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10554643-Bone Neoplasms,
pubmed-meshheading:10554643-Child,
pubmed-meshheading:10554643-Combined Modality Therapy,
pubmed-meshheading:10554643-Disease-Free Survival,
pubmed-meshheading:10554643-Female,
pubmed-meshheading:10554643-Follow-Up Studies,
pubmed-meshheading:10554643-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:10554643-Humans,
pubmed-meshheading:10554643-Male,
pubmed-meshheading:10554643-Neoadjuvant Therapy,
pubmed-meshheading:10554643-Neoplasm Recurrence, Local,
pubmed-meshheading:10554643-Neoplasms, Multiple Primary,
pubmed-meshheading:10554643-Osteotomy,
pubmed-meshheading:10554643-Patient Care Team,
pubmed-meshheading:10554643-Sarcoma, Ewing,
pubmed-meshheading:10554643-Survival Rate,
pubmed-meshheading:10554643-Treatment Outcome,
pubmed-meshheading:10554643-Whole-Body Irradiation
|
pubmed:year |
1999
|
pubmed:articleTitle |
Multimodality diagnostics and megatherapy in poor prognosis Ewing's tumor patients. A single-center report.
|
pubmed:affiliation |
Department of Pediatric Hematology and Oncology, Heinrich Heine University Medical Center Düsseldorf. laws@uni-duesseldorf.de
|
pubmed:publicationType |
Journal Article
|